THE WIRE
As seen on the 24/7 Wall St. homepage on August 3, 2026.
BlossomHill Therapeutics revised its IPO terms, targeting a $125 million raise at $15 to $17 per share as biotech companies line up to go public ahead of potential regulatory headwinds.
Mentioned: BLSM